Results 131 to 140 of about 5,632 (146)
Some of the next articles are maybe not open access.
ACS Applied Materials & Interfaces, 2019
A persistent problem in modern health care derives from the overwhelming presence of antibiotic-resistant microbes on biomaterials, more specifically, fungal growth on metal-based implants. This study seeks to investigate the antifungal properties of low-level electrochemical treatments delivered using titanium electrodes against Candida albicans.
Eloise Parry-Nweye +6 more
openaire +2 more sources
A persistent problem in modern health care derives from the overwhelming presence of antibiotic-resistant microbes on biomaterials, more specifically, fungal growth on metal-based implants. This study seeks to investigate the antifungal properties of low-level electrochemical treatments delivered using titanium electrodes against Candida albicans.
Eloise Parry-Nweye +6 more
openaire +2 more sources
Pharmacokinetics and tolerance of fluconazole suppositories in healthy volunteers.
Arzneimittel-Forschung, 1993Fluconazole (Diflucan, CAS 86386-73-4) suppositories offer a novel way to administer this systemically active antimycotic. The pharmacokinetics and toleration of this new formulation have now been examined in healthy adult volunteers. In crossover experiments the bioequivalence was demonstrated for 200 mg suppositories and 200 mg capsules, and for 25 ...
G, Pfaff +5 more
openaire +1 more source
Folia Microbiologica, 2014
The influence of acidic (5.6) and neutral (7.0) pH and glucose concentrations (0.9 and 2 %) was determined in in vitro biofilm formation and the cell surface hydrophobicity (CSH) in fluconazole (FLC) susceptible and tolerant yeasts of Candida albicans.
Anna, Kolecka +2 more
openaire +2 more sources
The influence of acidic (5.6) and neutral (7.0) pH and glucose concentrations (0.9 and 2 %) was determined in in vitro biofilm formation and the cell surface hydrophobicity (CSH) in fluconazole (FLC) susceptible and tolerant yeasts of Candida albicans.
Anna, Kolecka +2 more
openaire +2 more sources
Medizinische Klinik (Munich, Germany : 1983), 1992
50 HIV-positive patients (CDC stage III to VI) with oral candidiasis proven by culture and typical clinical findings were treated with fluconazole (50 to 100 mg/day) over a period of eight to 22 days. After completion of treatment, clinical signs of oral candidiasis had disappeared in 45/50 patients. In 10/50 patients, however, increased concentrations
B, Tschechne +5 more
openaire +1 more source
50 HIV-positive patients (CDC stage III to VI) with oral candidiasis proven by culture and typical clinical findings were treated with fluconazole (50 to 100 mg/day) over a period of eight to 22 days. After completion of treatment, clinical signs of oral candidiasis had disappeared in 45/50 patients. In 10/50 patients, however, increased concentrations
B, Tschechne +5 more
openaire +1 more source
The stress-protectant molecule trehalose mediates fluconazole tolerance in Candida glabrata
Abstract The incidence of non- albicans Candida infections has witnessed a substantial rise in recent decades. Candida glabrata (Nakaseomyces glabratus) , an opportunistic human fungal pathogen, is accountable for both superficial mucosal and life-Qingjuan Zhu +6 more
openaire +1 more source
Impact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection
Mycoses, 2021Judith Berman +2 more
exaly
ABSTRACT Cryptococcus neoformans ( Cn ) is an opportunistic fungal microorganism that causes life-threatening meningoencephalitis. During the infection, the microbial population is heterogeneously composed of cells with varying generational ages, with older cells ...
Kyungyoon Yoo +3 more
openaire +2 more sources
Kyungyoon Yoo +3 more
openaire +2 more sources
Aneuploidy Mediates Rapid Adaptation to a Subinhibitory Amount of Fluconazole in Candida albicans
Microbiology Spectrum, 2023Yuanying Jiang, , Tian-Hua Yan
exaly